The United kingdom Startup Ecosystem

Overview

The United Kingdom has a thriving startup ecosystem, particularly centered in London, which is a major global tech hub. As of 2023, the UK is home to approximately 30,000 startups. The UK government supports innovation through initiatives like the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS), which provide tax incentives for investors. In 2022, UK startups raised over £30 billion in venture capital.

Size of the Market

The UK startup ecosystem is substantial, with around 30,000 startups as of 2023. In 2022, UK startups raised over £30 billion in venture capital, indicating strong investor confidence and a robust market for entrepreneurial ventures. This financial support is critical for the growth and sustainability of new businesses.

Key Strengths

Key strengths of the UK market include a strong financial sector, world-class universities, and a diverse talent pool. The UK is known for its strengths in fintech, healthtech, and creative industries. London is a hotspot for fintech innovation, housing numerous unicorns such as Revolut and TransferWise.

Major Hubs

London remains the central hub for startups in the UK, particularly excelling in fintech and creative industries. The city is home to numerous high-growth startups and unicorns. Its position as a global financial center attracts significant venture capital and talent.

Emerging Hubs

Other cities like Manchester, Edinburgh, and Cambridge are making significant contributions to the startup landscape. Manchester is known for its tech and media industries, Edinburgh excels in fintech and AI, while Cambridge is renowned for life sciences and advanced manufacturing.

Support Systems

The UK startup ecosystem benefits from a robust support network of accelerators, incubators, and co-working spaces. Programs like Tech Nation and Innovate UK have been pivotal in fostering a supportive environment for startups, providing access to resources, mentorship, and funding.

Challenges

Challenges for UK startups include uncertainties related to Brexit, which have impacted investor confidence and regulatory frameworks. The changing economic landscape requires startups to navigate new trade agreements and regulatory environments, which can be complex and uncertain.

Opportunities and Future Outlook

Despite challenges, the UK remains a leader in innovation and entrepreneurship, with significant growth potential. The UK's strategic location and strong ties with international markets provide startups with opportunities for global expansion. Additionally, the emphasis on sustainability and green technology is driving innovation in sectors such as clean energy and sustainable transportation.

Resilience and Adaptability

The UK startup ecosystem is characterized by its resilience and adaptability. Programs like Tech Nation and Innovate UK support continuous development. The emphasis on sustainability and innovation positions the UK as a key player in the global startup ecosystem. As the UK continues to adapt to post-Brexit realities, its startup ecosystem is poised for further growth and development.

Angel Investment trends in the United kingdom

overlay landing page

We found 26 VC firms in the United kingdom investing in Cannabis on Angels Partners

Deerfield Management
Investing in Software (Web Marketplace Saas..) &b...
 New York City - Tel Aviv, U.S.A.
  • main investor picture
    Steve Anastos
    Principal
  • main investor picture
    Adam Greene
    Partner
  • main investor picture
    Jean Kim
    Partner
  • main investor picture
    Andrew ElBardissi
    Partner
  • main investor picture
    Jason Fuller
    Partner
  • main investor picture
    Sumner Anderson
    Partner
  • main investor picture
    Kevin Berg
    Partner
  • main investor picture
    Vince Mellet
    Partner
  • main investor picture
    Terence Karnal
    Partner
  • main investor picture
    Abraham Kometz
    Partner
  • main investor picture
    Adam Grossman
    Partner
  • main investor picture
    Alexis Cazé
    Partner
  • main investor picture
    Alison Stamas
    Associate
  • main investor picture
    Cameron Wheeler
    Partner
  • main investor picture
    Crystal Wright
    Associate
  • main investor picture
    Eddie Yang
    Analyst
  • main investor picture
    Elise Wang
    Partner
  • main investor picture
    Howard Furst
    Partner
  • main investor picture
    Jackson Harvey
    Analyst
  • main investor picture
    Konstantinos Aprilakis
    Partner
  • main investor picture
    Peter Steelman
    Partner
  • main investor picture
    Bharath Ganesan
    Principal
  • main investor picture
    Steven Hochberg
    Partner
  • main investor picture
    Gilan Megeed
    Principal
  • main investor picture
    Leslie Henshaw
    Partner
  • main investor picture
    Shumaila Irshad
    Analyst
  • main investor picture
    Vincent Mellet
    Partner
  • main investor picture
    Wenxi Chen
    Analyst
  • main investor picture
    Zheng Su
    Partner
Investor Picture
Previous Investments
  • Ardelyx: $110000000 (Other)
  • Recovery Centers of America: $100000000 (Other)
  • Oncorus: $89500000 (Later stage VC)
  • Oncorus, Inc.: $57000000 (Early stage VC)
  • Shockwave Medical: $45000000 (Later stage VC)
  • Fractyl Laboratories: $44000000 (Later stage VC)
  • Synlogic: $42000000 (Later stage VC)
  • SentreHEART: $35000000 (Later stage VC)
  • Phoenix Nuclear Labs: $12000000 (Later stage VC)
  • Epic Sciences:
  • Cystetic Medicines: $3850000 (Early Stage VC)
  • Pleno: $40000000 (Series A)
  • MMI: $75000000 (Series B)
  • Aurion Biotechnologies: $120000000 (Venture Round)
  • HearMe: $2000000 (Series A)
  • Spectrawave: $13000000 (Series A)
  • Liquid Wire: $10000000 (Series A)
  • Meditrina: $10000000 (Series Unknown)
  • Phoenix: $12000000 (Series Unknown)
  • SHINE Technologies: $130000000 (Series Unknown)
  • Perceive Biotherapeutics: $78000000 (Series B)
  • Vicinitas Therapeutics: $65000000 (Series A)
  • Ribon Therapeutics: $65000000 (Series C)
  • Nuvalent: $140000000 (Series B)
  • Nuvalent: $50000000 (Series A)
  • Pairwise Plants: $90000000 (Series B)
  • Pairwise Plants: $25000000 (Series A)
  • Neomorph: $110000000 (Series A)
  • Homology Medicines: $84000000 (Series B)
  • Homology Medicines: $44000000 (Series A)
  • Blade Therapeutics: $45000000 (Series B)
  • Jaguar Gene Therapy: $140000000 (Series B)
  • Jaguar Gene Therapy: (Series A)
  • Happify: $73000000 (Series D)
  • Great Lakes Discoveries LLC: $130000000 (Undisclosed)
  • ARTMS: $19000000 (Series A)
  • Four Points Innovation: $130000000 (Undisclosed)
  • The Johns Hopkins University: $65000000 (Series Unknown)
  • Infinity Pharmaceuticals: $100000000 (Post Ipo Debt)
  • MannKind: $160000000 (Post Ipo Debt)
  • Covagen: $66000000 (Series B)
  • Xlumena: $25000000 (Series C)
  • Xlumena: $7000000 (Series B)
  • Adaptive Phage Therapeutics: $41000000 (Series B)
  • Mirum Pharmaceuticals: $120000000 (Series A)
  • AveXis: $65000000 (Series D)
  • AveXis: $10000000 (Series C)
  • Audentes Therapeutics: $43000000 (Series B)
  • Hana Biosciences: $100000000 (Private Equity)
  • Altus Pharmaceuticals: $51000000 (Series C)
  • Actio Biosciences: $55000000 (Series A)
  • Jounce Therapeutics: $47000000 (Series A)
  • Crossover Health: $170000000 (Series D)
  • Curation Health: (Series A)
  • Concert Genetics: (Series Unknown)
  • CambridgeSoft: $31000000 (Series Unknown)

Deerfield Management

New York City - Tel Aviv, U.S.A.

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • HealthTech (& Fitness) • Cannabis • Gaming (& eSports) • Analytics • Cloud Services (& Infrastructure) • Material Science • Medical Devices (& Hospital Services) • Aerospace (& Defense) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology • Consumer • Pharmaceutical (& Medicine)

Description

Deerfield Management is a venture capital firm which specializes in seed, early stage and later stage investments. The firm invests in the healthcare, pharmaceutical and biotechnology sectors. The firm is based in New York, New York with additional offices in Shanghai, China and Epalinges, Switzerland.

Daniel Jones
Investing in Software (Web Marketplace Saas..) &b...
 Munich Germany , Lond..., U.K.
Investor Picture

Daniel Jones

Munich Germany - London - Paris France - Barcelona Spain - Berlin Germany - Hong Kong - Mumbai India - Singapore - Amsterdam Netherlands - Madrid Spain - New Delhi India - Dubai United Arab Emirates - Stockholm Sweden - Oslo Norway, U.K.

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • CleanTech • HealthTech (& Fitness) • Cannabis • Logistics (& Distribution)

Description

Founder JobStack, Inc. • Investor @google, @venmo • Studied at @university-of-california-santa-barbara

Michael Miller
Investing in Software (Web Marketplace Saas..) &b...
 Beverly Hills Califor..., U.S.A. - U.K. - India
Investor Picture

Michael Miller

Beverly Hills California - London - New York City (NY) - Chicago Illinois - Bethesda Maryland - Indianapolis Indiana - Annapolis Maryland - Bellevue Washington - Houston Texas - Washington D.C - Indiana - Virginia - Texas - Illinois, U.S.A. - U.K. - India

Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Logistics (& Distribution)

Description

Perseus is a merchant bank and private equity fund management company headquartered in Washington, D.C., with an office in New York and an associated advisory firm in Munich. Perseus has invested in numerous growth equity, turnaround, and buyout transactions in the United States, Canada, and Western Europe. Perseus manages seven private equity funds and makes control equity investments in middle market companies that offer opportunities for value creation and enhancement. Since its inception in 1995, Perseus has made investments in more than 60 portfolio companies in a wide variety of industries in which Perseus and its principals have expertise, including energy, environmental, and engineering technologies; healthcare; and branded consumer products. Perseus has raised more than $1.6 billion in capital commitments. Perseus Partners VII, L.P., which was established in 2006, is a $602 million fund focused on control investments in middle market growth equity transactions principally in the energy, environmental, and engineering technology, healthcare, and branded consumer products sectors. This fund has been fully committed or reserved. Perseus also co-manages a $449 million fund that invests exclusively in life sciences companies. Growth equity and turnaround investing have been core investment focuses of Perseus since inception, supplemented by occasional opportunistic leveraged buyouts when supported by appropriate market conditions.

Noah Liot
Investing in IT (& TMT) • Cannabis • Bl...
 Switzerland , Monaco ..., U.K.
Investor Picture

Noah Liot

Switzerland - Monaco - Paris France - London United Kingdom - Geneva Switzerland - France - U.K., U.K.

Investing In

IT (& TMT) • Cannabis • Blockchain (& Cryptos)

Description

Leader in HFT, Algo Trading & Machine Learning (FinTech), A problem solver and innovative thinker. A hyperactive caffeine junky, para-jumper, diver, adventurer.

Investor Picture
Previous Investments
  • Daplie: $360000
  • SalaryFinance: $40000000 (Later stage VC)
  • Salary Finance: $32799999 (Later stage VC)
  • Bijou Commerce: $2000000 (Later stage VC)

Charles Stuart Mindenhall

London, United Kingdom - U.K., U.K.

Investing In

IT (& TMT) • Cannabis • Investment Management • Mobile

Description

Charles Mindenhall is a Co-Founder at Blenheim Chalcot. He also serves as a Chairman at Bijou Commerce. Blenheim Chalcot traces its roots back to netdecisions which Charles and his business partner Manoj Badale founded back in 1998. Blenheim Chalcot specialises in building digital businesses that transform industries. It has portfolio sales of over £300m, more than 3,000 employees, and a successful track record of over 40 companies across IT services and software platforms, financial services, education and media. Charles is a Trustee of the Royal Foundation of the Duke and Duchess of Cambridge and Prince Harry. He chairs OnSide London and the Technology Trust and is a Trustee of OnSide, iCould and the Bridges Charitable Trust. Charles has an MA in Philosophy and Psychology from Christ Church, Oxford University, and was formerly at Monitor Company. He is also the Co-founder and serves as the Chairman at Fuse.

Investor Picture
Previous Investments
  • Grade:

Tristan Capital Partners

London, U.K.

Investing In

Hardware (& Manufacturing) • CleanTech • Cannabis • Healthcare (& Wellness)

Description

Lundon-based real estate investment management company, specializing in investment strategies in all property types across the UK and continental Europe for select institutional and private investors. Pan-European real estate investment funds include "core-plus" and "value added/opportunistic" strategies with total assets under management of ?3.0bn.

  • main investor picture
    Oliver Thomas
    Partner
  • main investor picture
    Charles Covell
    Partner
  • main investor picture
    David Olsson
    Partner
  • main investor picture
    Edward Brown
    Principal
Investor Picture
Previous Investments
  • Softomotive: $25000000 (Later stage VC)
  • Omilia Natural Language Solutions: $20000000 (Later stage VC)

Grafton Capital

London, U.K.

Investing In

Software (Web Marketplace Saas..) • IT (& TMT) • Businesses Solutions • Hardware (& Manufacturing) • Cannabis • Logistics (& Distribution) • Robotics • Healthcare (& Wellness)

Description

Grafton Capital is a growth investment firm that also specializes in venture capital investments. The firm invests in the business software, business data and online marketplaces sectors. It was founded in 2014 and is based in London, United Kingdom.

Irina Elena Haivas
Investing in BioTech • A.I. (& Big Data) &bu...
 London, U.K.
Investor Picture
Previous Investments
  • NFTPort: $26000000 (Series A)
  • Y42: $31000000 (Series A)
  • LabGenius: $15000000 (Series A)
  • Qatalog: $15000000 (Series A)
  • Healx: $56000000 (Series B)
  • Kheiron: $22000000 (Series A)
  • Daye: $6000000 (Seed)
  • Accurx: $11000000 (Series A)

Irina Elena Haivas

London, U.K.

Investing In

BioTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Autonomous vehicles (& Cars) • Robotics

Description

Partner at Atomico

Neil Mahapatra
Investing in Software (Web Marketplace Saas..) &b...
 London, United Kingdom
Investor Picture

Neil Mahapatra

London, United Kingdom

Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Education • FinTech (& Financials services) • Cannabis • Food & Beverage • Logistics (& Distribution)

Antonin Cohen
Investing in Cannabis
 Europe - U.K., U.K.
Investor Picture

Antonin Cohen

Europe - U.K., U.K.

Investing In

Cannabis

Description

Founder @meetharmony. Bring back the power of nature. Strong business/tech/science background. Previously Manager France @hoteltonight.

Investor Picture
Previous Investments
  • Plena Global:
  • Plena:

James Innes

London, United Kingdom - U.K., U.K.

Investing In

Cannabis • Life Science

Investor Picture
Previous Investments
  • Plena Global:
  • Plena:

Kingsley Wilson

London, United Kingdom - U.K., U.K.

Investing In

Cannabis • Life Science

Join the community

Connect with investors & startup founders

Comprehensive Guides to Finding Startup Investorsin the United kingdom

By clicking on "Create Account" you accept our terms of service

Already have an account?
Login
founder clement

Clément Perrot - Associate Partners @ Angels Partners

"Angels Partners is here to help startup founders secure meetings with investors.
We provide access to a number of services centered around fundraising."

taylor founder testimonial

Kevin Creusy - Founder & CEO, Upfluence



"I launched a campaign and booked 12 meetings in three weeks. There just isn't anything comparable online yet."

founder testimonial

Alex Cammarano - Founder of Daylighted



"Within a few weeks, we launched a successful investor outreach campaign and arranged dozens of pitches."


Create An Account
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
32 New Startups Started their fundraising over the last 7 days